Follow-up Study of the Alzheimer's Disease Anti-Inflammatory Prevention Trial

Status unconfirmed

Conditions studied: Alzheimer Disease, Dementia

In brief

The Alzheimer's Disease Anti-inflammatory Prevention Trial - Follow-up Study (ADAPT-FS) will continue observations of the declared primary outcomes of the Alzheimer's Disease Anti-inflammatory Prevention Trial (ADAPT) in the cohort previously established for that trial.

Key facts

Study ID

NCT01417130

Run by

Seattle Institute for Biomedical and Clinical Research

People needed

1650

Starts

2009-08-01

Expected to finish

2012-08-01

Last updated by the study team

2012-01-09

Who can join

Age: 75 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subjects must have been enrolled previously in the Alzheimer's Disease Anti-Inflammatory Prevention Trial (ADAPT).

You may not qualify if…

• Individuals not previously enrolled in the ADAPT trial.

Where it is running

• Banner Sun Health Research Institute — Sun City, Arizona, United States
• The Roskamp Institute — Sarasota, Florida, United States
• The Johns Hopkins University — Baltimore, Maryland, United States
• Boston University School of Medicine — Boston, Massachusetts, United States
• Monroe Community Hospital — Rochester, New York, United States
• Veterans Affairs Puget Sound Health Care System — Seattle, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.